Patents by Inventor Donogh P. O'Brien

Donogh P. O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI)
    Patent number: 6986894
    Abstract: The present invention related to a method and therapeutic composition for the treatment of coagulation disorders comprising administration of a lipoprotein associated coagulation inhibitor.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: January 17, 2006
    Assignee: Genentech, Inc.
    Inventors: Donogh P. O'Brien, Gordon A. Vehar
  • Method and therapeutic compositions for the treatment of myocardial infarction
    Publication number: 20030206904
    Abstract: The present invention relates to a method and therapeutic composition for the treatment of myocardial infarction comprising administration of a tissue factor protein antagonist and a thrombolytic agent.
    Type: Application
    Filed: August 8, 2001
    Publication date: November 6, 2003
    Applicant: Genentech, Inc.
    Inventors: Donogh P. O'Brien, Gordon A. Vehar
  • Methods of neutralizing coagulation with anti-tissue factor antibodies
    Patent number: 6274142
    Abstract: The present invention relates to a method and therapeutic composition for the treatment of myocardial infarction comprising administration of a tissue factor protein antagonist and a thrombolytic agent. In addition, the present invention relates to methods of neutralizing coagulation, including in patients with deep vein thrombosis, with anti-tissue factor antibodies.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 14, 2001
    Assignee: Genentech, Inc.
    Inventors: Donogh P. O'Brien, Gordon A. Vehar
  • Method and therapeutic compositions for the treatment of myocardial infarction
    Patent number: 5589173
    Abstract: The present invention relates to a method and therapeutic composition for the treatment of myocardial infarction comprising administration of a tissue factor protein antagonist and a thrombolytic agent.
    Type: Grant
    Filed: June 16, 1994
    Date of Patent: December 31, 1996
    Assignee: Genentech, Inc.
    Inventors: Donogh P. O'Brien, Gordon A. Vehar, Josiah N. Wilcox
  • Treatment of bleeding disorders using lipid-free tissue factor protein
    Patent number: 5017556
    Abstract: A method and therapeutic composition for the treatment of bleeding disorders, for example those characterized by a tendency toward hemorrhage or a hypercoagulative state, by the administration of tissue factor protein or antagonists thereof.
    Type: Grant
    Filed: March 8, 1989
    Date of Patent: May 21, 1991
    Assignee: Genentech, Inc.
    Inventors: Donogh P. O'Brien, Gordon A. Vehar